MSGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Madison Square Garden Sports Corp (MSGS) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While there are positive catalysts such as analyst upgrades and potential spin-offs, the company's recent financial performance shows declining revenue and gross margin. Additionally, there are no strong proprietary trading signals or significant trading trends to support an immediate buy decision.
The technical indicators show a mixed picture. The MACD is positive and contracting, suggesting some bullish momentum. The RSI is neutral at 65.035, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 337.795 and 354.013, while support levels are at 285.293 and 269.075.
Analysts have raised price targets recently, with JPMorgan increasing the target to $400 and maintaining an Overweight rating.
The company is exploring a potential spin-off of the New York Knicks and Rangers, which could unlock value.
Citi highlighted the possibility of a minority stake sale to close the valuation gap.
Financial performance in Q1 2026 shows a 25.99% YoY revenue drop and a 6.20% decline in gross margin.
Wolfe Research downgraded the stock, citing minimal catalysts for significant upside without a major ownership change.
No significant hedge fund or insider trading trends, and no recent news or congress trading data.
In Q1 2026, revenue dropped by 25.99% YoY to $39.45M. Net income improved by 16.74% YoY but remains negative at -$8.81M. EPS increased by 19.35% YoY to -$0.37, and gross margin declined by 6.20% YoY to 80.28.
Analysts are generally positive, with multiple firms raising price targets. JPMorgan sees a high intention to execute a spin-off, and Citi highlights the valuation gap. However, Wolfe Research downgraded the stock, citing limited catalysts for upside.
